iRhythm Technologies (IRTC) Stock: Buy, Sell, or Hold?
IRTC - iRhythm Technologies, Inc
$121.06
1.42 (1.18%)
▲
5d:
+11.41%
30d:
+9.26%
90d:
+7.94%
WAIT
LOW Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Nov 05, 2026
12d
Get Alerted When IRTC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: IRTC shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: IRTC shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$60.64
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$37.65
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: IRTC is currently trading at $121.06, which is considered extended relative to its 30-day fair value range of $106.92 to $114.55. From a valuation perspective, the stock is trading at a discount (Forward PE: 96.0) compared to its historical average (116.2). Remarkably, the market is currently pricing in an annual earnings decline of 6.1% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, IRTC is showing sideways momentum. The price is approaching resistance at $122.50. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: IRTC scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $171.33 (+43.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, IRTC is showing sideways momentum. The price is approaching resistance at $122.50. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: IRTC scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $171.33 (+43.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$106.92 -
$114.55
Company Quality Score
44/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
38.5%
Protect Your Profits
Holding IRTC? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+5.7% above its trading range)
- BULLISH: Options cheap (IV 0th percentile)
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 43.2% below Wall St target ($171.33)
- WARNING: Composite score 44/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$106.92 -
$114.55
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$7.64
(6.3%)
Support & Resistance Levels
Support Level
$104.52
Resistance Level
$122.50
Current Trend
Sideways
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
96.05
Wall Street Target
$171.33
(+43.2%)
Revenue Growth (YoY)
20.1%
Profit Margin
-1.7%
Valuation Discount vs History
-6.1% cheaper
PE vs Historical
96.1 vs 116.2
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-6.1%
(market-implied from PE analysis)
1-Year Target
$112.34
(-6%)
2-Year Target
$105.49
(-12%)
3-Year Target
$99.05
(-17%)
3-Yr Target (if PE normalizes)
(PE: 96→116)
$119.83
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 96.1, Growth: 125.1%)
$403.78
(+238%)
Base:
(SPY PE: 19.9, Growth: 125.1%)
$83.49
(-30%)
Bear:
(PE: 16.9, Growth: 125.1%)
$70.97
(-41%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 96.1 to 116.2
Stabilization Target:
$144.74
(+21.0%)
PE Expansion Potential:
+21.0%
Share & Embed Analysis
Last updated: October 23, 2026 2:41 PM ET
Data refreshes hourly during market hours. Next update: 3:41 PM
Data refreshes hourly during market hours. Next update: 3:41 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IRTC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
EW
Edwards Lifesciences Corp |
STRONG BUY
29 analysts |
$102 | 58 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$96 | 46 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
28 analysts |
$121 | 52 HOLD |
|
SYK
Stryker Corporation |
STRONG BUY
29 analysts |
$363 | 37 SELL |
|
CATX
Perspective Therapeutics… |
STRONG BUY
14 analysts |
$12 | 56 HOLD |
Advanced IRTC Option Strategies
Professional options setups generated by AI based on today's IRTC price and gamma walls.
